Have a personal or library account? Click to login

Cardiac Stem Cell-based Regenerative Therapy for the Ischemic Injured Heart — a Short Update 2017

Open Access
|Jul 2017

References

  1. 1. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-1209. doi: 10.1056/NEJMoa055706.10.1056/NEJMoa055706
  2. 2. Quyyumi AA, Vasquez A, Kereiakes DJ, et al. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017;120:324-331. doi: 10.1161/CIRCRESAHA.115.308165.10.1161/CIRCRESAHA.115.308165
  3. 3. Wollert KC, Meyer GP, Müller-Ehmsen J, et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur Heart J. 2017. doi: 10.1093/eurheartj/ehx188. [Epub ahead of print]10.1093/eurheartj/ehx188
  4. 4. Gyöngyösi M, Wojakowski W, Lemarchand P, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116:1346-1360. doi: 10.1161/CIRCRESAHA.116.304346.10.1161/CIRCRESAHA.116.304346
  5. 5. Fisher SA, Doree C, Mathur A, Martin-Rendon E. Metaanalysis of cell therapy trials for patients with heart failure. Circ Res. 2015;116:1361-1377. doi: https://doi.org/10.1161/CIRCRESAHA.116.304386.10.1161/CIRCRESAHA.116.304386
  6. 6. Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015;9:CD006536. doi: 10.1002/14651858.CD006536.pub4.10.1002/14651858.CD006536.pub4
  7. 7. Nowbar AN, Mielewczik M, Karavassilis M, et al. DAMASCENE writing group. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014;348:g2688. doi: 10.1136/bmj.g2688.10.1136/bmj.g2688
  8. 8. Bartunek J, Terzic A, Davison BA, et al. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, shamcontrolled CHART-1 clinical trial. Eur Heart J. 2017;38:648-660. doi: https://doi.org/10.1093/eurheartj/ehw543.10.1093/eurheartj/ehw543
  9. 9. Fernández-Avilés F, Sanz-Ruiz R, Climent AM, et al. Global position paper on cardiovascular regenerative medicine: Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) international group for the comprehensive cardiovascular application of regenerative medicinal products. Eur Heart J. 2017. doi: 10.1093/eurheartj/ehx248. [Epub ahead of print]10.1093/eurheartj/ehx248
DOI: https://doi.org/10.1515/jce-2017-0009 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 81 - 83
Submitted on: May 25, 2017
Accepted on: Jun 2, 2017
Published on: Jul 11, 2017
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Mariann Gyöngyösi, Dominika Lukovic, Katrin Zlabinger, Ljubica Mandic, Johannes Winkler, Alfred Gugerell, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.